| Entity | Extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q12). |
| Disease | rare type of sarcoma (2.3% of all soft tissue sarcomas) characteristically involving the deep, soft tissues of the extremities; morphological resemblance to embryonic cartilage. |
| Hybrid/Mutated Gene | EWSR1-TEC |
| Abnormal Protein | N-terminal transactivation domain of EWSR1 fused to the entire TEC protein. |
| | |
| Entity | Extraskeletal myxoid chondrosarcoma with t(9;17)(q22;q11). |
| Disease | rare type of sarcoma (2.3% of all soft tissue sarcomas) characteristically involving the deep, soft tissues of the extremities; morphological resemblance to embryonic cartilage. |
| Hybrid/Mutated Gene | TAF2N-TEC |
| Abnormal Protein | N-terminal transactivation domain of TAF2N fused to the entire TEC protein. |
| | |
| Entity | Extraskeletal myxoid chondrosarcoma with t(9;15)(q22;q21). |
| Disease | rare type of sarcoma (2.3% of all soft tissue sarcomas) characteristically involving the deep, soft tissues of the extremities; morphological resemblance to embryonic cartilage. |
| Hybrid/Mutated Gene | TCF12-TEC |
| Abnormal Protein | N-terminal domain of TCF12 fused to the entire TEC protein; the N-terminal of TCF12 shows no sequence homology to the N-terminals of EWSR1 or TAF2N. |
| | |
| Molecular cloning of a novel thyroid/steroid receptor superfamily gene from cultured rat neuronal cells. |
| Ohkura N, Hijikuro M, Yamamoto A, Miki K |
| Biochemical and biophysical research communications. 1994 ; 205 (3) : 1959-1965. |
| PMID 7811288 |
| |
| The isolation and characterization of MINOR, a novel mitogen-inducible nuclear orphan receptor. |
| Hedvat CV, Irving SG |
| Molecular endocrinology (Baltimore, Md.). 1995 ; 9 (12) : 1692-1700. |
| PMID 8614405 |
| |
| Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. |
| Labelle Y, Zucman J, Stenman G, Kindblom LG, Knight J, Turc-Carel C, Dockhorn-Dworniczak B, Mandahl N, Desmaze C, Peter M |
| Human molecular genetics. 1995 ; 4 (12) : 2219-2226. |
| PMID 8634690 |
| |
| Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. |
| Clark J, Benjamin H, Gill S, Sidhar S, Goodwin G, Crew J, Gusterson BA, Shipley J, Cooper CS |
| Oncogene. 1996 ; 12 (2) : 229-235. |
| PMID 8570200 |
| |
| Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma. |
| Attwooll C, Tariq M, Harris M, Coyne JD, Telford N, Varley JM |
| Oncogene. 1999 ; 18 (52) : 7599-7601. |
| PMID 10602520 |
| |
| The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator. |
| Labelle Y, BussiŪres J, Courjal F, Goldring MB |
| Oncogene. 1999 ; 18 (21) : 3303-3308. |
| PMID 10359536 |
| |
| Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma. |
| Sjgren H, Meis-Kindblom J, Kindblom LG, Aman P, Stenman G |
| Cancer research. 1999 ; 59 (20) : 5064-5067. |
| PMID 10537274 |
| |
| Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21). |
| Sjgren H, Wedell B, Meis-Kindblom JM, Kindblom LG, Stenman G |
| Cancer research. 2000 ; 60 (24) : 6832-6835. |
| PMID 11156374 |
| |
| The AF2 domain of the orphan nuclear receptor TEC is essential for the transcriptional activity of the oncogenic fusion protein EWS/TEC. |
| Maltais A, Filion C, Labelle Y |
| Cancer letters. 2002 ; 183 (1) : 87-94. |
| PMID 12049818 |
| |
| The EWS/NOR1 fusion gene product gains a novel activity affecting pre-mRNA splicing. |
| Ohkura N, Yaguchi H, Tsukada T, Yamaguchi K |
| The Journal of biological chemistry. 2002 ; 277 (1) : 535-543. |
| PMID 11673470 |
| |
| The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas. |
| Laflamme C, Filion C, Bridge JA, Ladanyi M, Goldring MB, Labelle Y |
| Cancer research. 2003 ; 63 (2) : 449-454. |
| PMID 12543801 |
| |